Impact of weight-loss surgery and diabetes status on serum ALT levels

Obesity Surgery

Volumn 22, Issue 10, 2012, Pages 1540-1547

  Xourafas, Dimitrios ^a   Ardestani, Ali ^a   Ashley, Stanley W ^a   Tavakkoli, Ali ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Bariatric surgery; LAP BAND; Metabolic syndrome; RYGB; T2DM

Indexed keywords

ALANINE AMINOTRANSFERASE; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; BARIATRIC SURGERY; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; GASTRIC BANDING; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; ROUX EN Y GASTRIC BYPASS SURGERY; SEX DIFFERENCE; STOMACH BYPASS; TREATMENT RESPONSE; WEIGHT REDUCTION;

ADULT; AGED; ALANINE TRANSAMINASE; ANALYSIS OF VARIANCE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; GASTRIC BYPASS; GASTROPLASTY; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INSULIN; LAPAROSCOPY; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY, MORBID; POSTOPERATIVE PERIOD; RETROSPECTIVE STUDIES; WEIGHT LOSS;

EID: 84866075193     PISSN: 09608923     EISSN: 17080428     Source Type: Journal    
DOI: 10.1007/s11695-012-0677-1     Document Type: Article

References (24)

1. Streib L. Worlds Fattest Countries. February 8, 2007. Available at www.Forbes.com. Accessed 16 May 2008.
2. Matsuzawa Y. The metabolic syndrome and adipocytokines. FEBS Lett. 2006;580(12):2917-21. Epub 2006 Apr 21.
3. Must A, Jacques PF, Dallal GE, et al. Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935. N Engl J Med. 1992;327(19):1350-5.
4. Sjöström L, Narbro K, Sjöström CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. Swedish Obese Subjects Study. N Engl J Med. 2007;357(8):741-52.
5. Adams TD, Gress RE, Smith SC, et al. Long-term mortality after gastric bypass surgery. N Engl J Med. 2007;357(8):753-61.
6. Stranges S, Dorn JM, Muti P, et al. Body fat distribution, relative weight, and liver enzyme levels: a population-based study. Hepatology. 2004;39(3):754-63.
7. Schindhelm RK, Dekker JM, Nijpels G, et al. Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study. Atherosclerosis. 2007;191(2):391-6. Epub 2006 May 8.
8. Sattar N, Scherbakova O, Ford I, et al. Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study. West of Scotland coronary prevention study. Diabetes. 2004;53(11):2855-60.
9. Goessling W, Massaro JM, Vasan RS, et al. Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease. Gastroenterology. 2008;135(6):1935-44. 1944.e1. Epub 2008 Sep 20.
10. Prati D, Taioli E, Zanella A, et al. Updated definitions of healthy ranges for serum alanine aminotransferase levels. Ann Intern Med. 2002;137(1):1-10.
11. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology. 2003;37(5):1202-19. Review. Erratum in: Hepatology. 2003 Aug;38(2):536.
12. Van der Poorten D, Kenny DT, Butler T, et al. Liver disease in adolescents: a cohort study of high-risk individuals. Hepatology. 2007;46(6):1750-8.
13. Vozarova B, Stefan N, Lindsay RS, et al. High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes. 2002;51(6):1889-95.
14. Ruhl CE, Everhart JE. Trunk fat is associated with increased serum levels of alanine aminotransferase in the United States. Gastroenterology. 2010;138(4):1346-56. 1356.e1-3. Epub 2010 Jan 11.
15. Seppälä-Lindroos A, Vehkavaara S, Häkkinen AM, et al. Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men. J Clin Endocrinol Metab. 2002;87(7):3023-8.
16. Mathurin P, Hollebecque A, Arnalsteen L, et al. Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease. Gastroenterology. 2009;137(2):532-40. Epub 2009 May 4.
17. Dixon JB, Bhathal PS, O'Brien PE. Weight loss and non-alcoholic fatty liver disease: falls in gamma-glutamyl transferase concentrations are associated with histologic improvement. Obes Surg. 2006;16(10):1278-86.
18. Di Bonito P, Sanguigno E, Di Fraia T, et al. Association of elevated serum alanine aminotransferase with metabolic factors in obese children: sex-related analysis. Metabolism. 2009;58(3):368-72.
19. Judi L, Toukan A, Khader Y, et al. Prevalence of elevated hepatic transaminases among Jordanian patients with type 2 diabetes mellitus. Ann Saudi Med. 2010;30(1):25-32.
20. Ruhl CE, Everhart JE. Epidemiology of nonalcoholic fatty liver. Clin Liver Dis. 2004;8(3):501-19. vii.
21. Zhang Y, Lu X, Hong J, et al. Positive correlations of liver enzymes with metabolic syndrome including insulin resistance in newly diagnosed type 2 diabetes mellitus. Endocrine. 2010;38(2):181-7. Epub 2010 Oct.
22. Busetto L, Tregnaghi A, De Marchi F, et al. Liver volume and visceral obesity in women with hepatic steatosis undergoing gastric banding. Obes Res. 2002;10(5):408-11.
23. Pontiroli AE, Pizzocri P, Librenti MC, et al. Laparoscopic adjustable gastric banding for the treatment of morbid (grade 3) obesity and its metabolic complications: a three-year study. J Clin Endocrinol Metab. 2002;87(8):3555-61.
24. De Luis DA, Aller R, Izaola O, et al. Relationship of insulin resistance and adipocytokines on serum alanine aminotransferase in presurgical morbid obese patients. Eur Rev Med Pharmacol Sci. 2009;13(6):413-8.